Aclaris Therapeutics, Inc. Common Stock (NASDAQ: ACRS) last traded at $6.41, up 1.26% on the session. The quote above updates while this page is open; the figures below are drawn from Aclaris Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Aclaris Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ACRS. Its market capitalisation is $943.54 million.
Valuation measures for Aclaris Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $943.54M |
|---|---|
| Enterprise value | $979.49M |
| Price / sales | 114.80 |
| Price / book | 7.57 |
| Beta | 0.57 |
Trailing-twelve-month figures tagged in Aclaris Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $8.22M |
|---|---|
| Net income (TTM) | -$75.74M |
| EPS (TTM) | -$0.580 |
| Operating margin | -1050.16% |
| Return on equity | -60.79% |
| Cash | $19.17M |
Range and volume for ACRS over the past 52 weeks.
| 52-week high | $6.52 |
|---|---|
| 52-week low | $1.74 |
| Volume | 2.21M |
| Average volume | 1.81M |
| Previous close | $6.33 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.